# Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin
> **Food and Drug Administration** · Final rule. · Published 2008-02-01 · Effective 2008-02-01 · 73 FR 6017
## Document
- **Document number:** E8-1906
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 73 FR 6017
- **CFR reference:** 21 CFR 522
- **Publication date:** 2008-02-01
- **Effective date:** 2008-02-01
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for veterinarian prescription use of tulathromycin injectable solution for the treatment of infectious bovine keratoconjunctivitis and the addition of a pathogen to the indication for use for treatment of swine respiratory disease.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2008/02/01/E8-1906/implantation-or-injectable-dosage-form-new-animal-drugs-tulathromycin)
---
*AI Analytics · CC0 1.0*